Literature DB >> 18566110

Predictors of mortality in acute lung injury during the era of lung protective ventilation.

E Seeley1, D F McAuley, M Eisner, M Miletin, M A Matthay, R H Kallet.   

Abstract

BACKGROUND: Lung protective ventilation has been widely adopted for the management of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Consequently, ventilator associated lung injury and mortality have decreased. It is not known if this ventilation strategy changes the prognostic value of previously identified demographic and pulmonary predictors of mortality, such as respiratory compliance and the arterial oxygen tension to inspired oxygen fraction ratio (Pao(2)/Fio(2)).
METHODS: Demographic, clinical, laboratory and pulmonary variables were recorded in 149 patients with ALI/ARDS. Significant predictors of mortality were identified in bivariate analysis and these were entered into multivariate analysis to identify independent predictors of mortality.
RESULTS: Hospital mortality was 41%. In the bivariate analysis, 17 variables were significantly correlated with mortality, including age, APACHE II score and the presence of cirrhosis. Pulmonary parameters associated with death included Pao(2)/Fio(2) and oxygenation index ((mean airway pressurexFio(2)x100)/Pao(2)). In unadjusted analysis, the odds ratio (OR) of death for Pao(2)/Fio(2) was 1.57 (CI 1.12 to 3.04) per standard deviation decrease. However, in adjusted analysis, Pao(2)/Fio(2) was not a statistically significant predictor of death, with an OR of 1.29 (CI 0.82 to 2.02). In contrast, oxygenation index (OI) was a statistically significant predictor of death in both unadjusted analysis (OR 1.89 (CI 1.28 to 2.78)) and in adjusted analysis (OR 1.84 (CI 1.13 to 2.99)).
CONCLUSIONS: In this cohort of patients with ALI/ARDS, OI was an independent predictor of mortality, whereas Pao(2)/Fio(2) was not. OI may be a superior predictor because it integrates both airway pressure and oxygenation into a single variable.

Entities:  

Mesh:

Year:  2008        PMID: 18566110      PMCID: PMC2771451          DOI: 10.1136/thx.2007.093658

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.

Authors:  Thomas J Nuckton; James A Alonso; Richard H Kallet; Brian M Daniel; Jean-François Pittet; Mark D Eisner; Michael A Matthay
Journal:  N Engl J Med       Date:  2002-04-25       Impact factor: 91.245

2.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

3.  The effect of acute respiratory distress syndrome on long-term survival.

Authors:  T A Davidson; G D Rubenfeld; E S Caldwell; L D Hudson; K P Steinberg
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome.

Authors:  E Wesley Ely; Arthur P Wheeler; B Taylor Thompson; Marek Ancukiewicz; Kenneth P Steinberg; Gordon R Bernard
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

6.  Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study.

Authors:  Christian Brun-Buisson; Cosetta Minelli; Guido Bertolini; Luca Brazzi; Jorge Pimentel; Klaus Lewandowski; Julian Bion; Jacques-André Romand; Jesús Villar; Adalbjörn Thorsteinsson; Pierre Damas; Apostolos Armaganidis; François Lemaire
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

7.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

8.  A new oxygenation index for reflecting intrapulmonary shunting in patients undergoing open-heart surgery.

Authors:  Mohamad F El-Khatib; Ghassan W Jamaleddine
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

9.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09

10.  Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome.

Authors:  Elisa Estenssoro; Arnaldo Dubin; Enrique Laffaire; Héctor S Canales; Gabriela Sáenz; Miriam Moseinco; Pierina Bachetti
Journal:  Intensive Care Med       Date:  2003-09-04       Impact factor: 17.440

View more
  62 in total

Review 1.  Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

Authors:  Michael A Matthay; B Taylor Thompson; Elizabeth J Read; David H McKenna; Kathleen D Liu; Carolyn S Calfee; Jae Woo Lee
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

2.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Feng Chen; Ednan K Bajwa; Peter F Clardy; Diana C Gallagher; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

3.  Fever is associated with delayed ventilator liberation in acute lung injury.

Authors:  Giora Netzer; David W Dowdy; Thelma Harrington; Satish Chandolu; Victor D Dinglas; Nirav G Shah; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl Shanholtz; Jeffrey D Hasday; Dale M Needham
Journal:  Ann Am Thorac Soc       Date:  2013-12

4.  Predicting Outcome in Mechanically Ventilated Pediatric Patients.

Authors:  Selman Kesici; Şenay Kenç; Ayşe Filiz Yetimakman; Benan Bayrakci
Journal:  J Pediatr Intensive Care       Date:  2019-12-03

Review 5.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

6.  Definition of ALI/ARDS.

Authors:  Krishnan Raghavendran; Lena M Napolitano
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

7.  Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.

Authors:  Liang Luo; Ciara M Shaver; Zhiguo Zhao; Tatsuki Koyama; Carolyn S Calfee; Julie A Bastarache; Lorraine B Ware
Journal:  Chest       Date:  2016-09-20       Impact factor: 9.410

8.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Authors:  Michael A Matthay; Carolyn S Calfee; Hanjing Zhuo; B Taylor Thompson; Jennifer G Wilson; Joseph E Levitt; Angela J Rogers; Jeffrey E Gotts; Jeanine P Wiener-Kronish; Ednan K Bajwa; Michael P Donahoe; Bryan J McVerry; Luis A Ortiz; Matthew Exline; John W Christman; Jason Abbott; Kevin L Delucchi; Lizette Caballero; Melanie McMillan; David H McKenna; Kathleen D Liu
Journal:  Lancet Respir Med       Date:  2018-11-16       Impact factor: 30.700

9.  Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.

Authors:  Melanie van der Heijden; Peter Pickkers; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Martijn P W J M Bouw; Johannes G van der Hoeven; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2009-06-24       Impact factor: 17.440

10.  Inhaled activated protein C: a novel therapy for acute lung injury?

Authors:  Kathleen D Liu; Mark R Looney; Michael A Matthay
Journal:  Crit Care       Date:  2009-05-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.